# The Impact of Remimazolam for Postoperative Sedation on the Left Ventricular Systolic Performance in Cardiac Surgery

> **NCT05041725** · PHASE4 · UNKNOWN · sponsor: **Konkuk University Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Remimazolam Injection [Byfavo]

## Key facts

- **NCT ID:** NCT05041725
- **Lead sponsor:** Konkuk University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05041725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05041725, "The Impact of Remimazolam for Postoperative Sedation on the Left Ventricular Systolic Performance in Cardiac Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05041725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*